Position in CDXS
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$16,829
New position
Shares Held
10,325
first reported quarter
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 25%
Shared 0%
None 75%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Pallas Capital Advisors LLC holds $23,981,428 across 32 Biotechnology names. CDXS ranks #30 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
40,610 | $6,863,902 | |
| 2 | RPRX |
Royalty Pharma plc
|
102,969 | $4,939,422 | |
| 3 | INCY |
Incyte Corp
|
33,157 | $3,120,736 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,680 | $2,070,675 | |
| 5 | EXEL |
Exelixis, Inc.
|
29,215 | $1,253,031 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,212 | $731,884 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,638 | $731,432 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
12,396 | $700,250 |
All Filings in CDXS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,829 | 10,325 | Shares | Sole | 2026-04-21 | |
| No filing history on record for this holder in this stock. | ||||||